GeneDx Holdings Corp. Financial and Nonfinancial Liabilities, Fair Value Disclosure
GeneDx Holdings Corp. (WGS) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-08-03
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $220.00K.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.67M.
- 2024-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $3.52M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 |
| 2026-03-31 | $220.00K 10-Q · filed 2026-05-04 |
| 2025-12-31 | $2.67M 10-Q · filed 2026-08-03 |
| 2024-12-31 | $3.52M 10-K · filed 2026-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |